Dr. Desai on the Ideal Patient for Bladder Preservation in Urothelial Cancer

Video

Neil Desai, MD, discusses the ideal patient for bladder preservation in urothelial cancer.

Neil Desai, MD, associate professor, radiation oncology, UT Southwestern Harold C. Simmons Comprehensive Cancer Center, discusses the ideal patient for bladder preservation in urothelial cancer.

There have been a substantial amount of research examining selection criteria for the ideal patient for bladder preservation, Desai says. These criteria include a smaller tumor size, the ability for surgeons to completely resect a tumor, the ability for patients to receive standard chemotherapy with concurrent radiation, and a lack of hydronephrosis, Desai explains.

When patients don’t meet some aspects of the selection criteria, it means they have a higher burden of disease, and bladder preservation may not provide as durable of control in patients with higher disease burden, Desai continues. It is important to differentiate selection criteria from eligibility, as patients not meeting the selection criteria could still be eligible for bladder preservation; rather, these patients have a higher risk of disease progression following preservation, Desai concludes.

Related Videos
Hye Sook Chon, MD, gynecologic oncologist, Gynecologic Oncology Program, Moffitt Cancer Center
Amma Asare, MD, PhD
Sundar Jagannath, MBBS
Elias Jabbour, MD
Rebecca Klisovic, MD
Axel Hauschild, MD, PhD, head, Skin Cancer Trial Center, University Hospital Schleswig-Holstein
David L. Porter, MD, director, Cell Therapy and Transplant, Jodi Fisher Horowitz Professor in Leukemia Care Excellence, Penn Medicine
Jubilee Brown, MD
Changchun Deng, MD, PhD
Laura J. Chambers, DO